Acadia Pharmaceuticals Company Profile (NASDAQ:ACAD)

About Acadia Pharmaceuticals

Acadia Pharmaceuticals logoACADIA Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines for central nervous system disorders. The Company's lead drug candidate, NUPLAZID (pimavanserin), is under development for the treatment of Parkinson's disease psychosis (PDP). NUPLAZID is a selective serotonin inverse agonist (SSIA), targeting 5-HT2A receptors. The Company's Pimavanserin is a chemical entity, which has completed Phase III development, and is indicated for the treatment of Parkinson's disease psychosis. NUPLAZID (pimavanserin) is a selective serotonin inverse agonist preferentially targeting the 5-HT2A receptor, a key serotonin receptor that plays a role in psychosis. Through this mechanism, NUPLAZID has demonstrated efficacy in Parkinson's disease psychosis in its Phase III pivotal trial and avoids the side effects of existing antipsychotics.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ACAD
  • CUSIP:
Key Metrics:
  • Previous Close: $32.70
  • 50 Day Moving Average: $33.17
  • 200 Day Moving Average: $32.69
  • 52-Week Range: $16.64 - $43.30
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -21.79
  • P/E Growth: -1.60
  • Market Cap: $3.63B
  • Outstanding Shares: 114,005,000
  • Beta: 3.46
Profitability:
  • Net Margins: -131,066.23%
  • Return on Equity: -64.25%
  • Return on Assets: -60.00%
Debt:
  • Current Ratio: 14.61%
  • Quick Ratio: 14.51%
Additional Links:
Companies Related to Acadia Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Acadia Pharmaceuticals (NASDAQ:ACAD) (?)
Ratings Breakdown: 3 Hold Ratings, 7 Buy Ratings
Consensus Rating:Buy (Score: 2.70)
Consensus Price Target: $46.33 (45.66% upside)

Analysts' Ratings History for Acadia Pharmaceuticals (NASDAQ:ACAD)
Show:
DateFirmActionRatingPrice TargetDetails
9/30/2016Cowen and CompanyReiterated RatingOutperform$42.00View Rating Details
9/25/2016HC WainwrightReiterated RatingBuy$60.00View Rating Details
8/25/2016Jefferies GroupReiterated RatingBuyView Rating Details
8/16/2016Piper Jaffray Cos.Reiterated RatingOverweight$44.00View Rating Details
8/10/2016JMP SecuritiesReiterated RatingBuy$45.00View Rating Details
8/5/2016AegisDowngradeBuy -> Hold$54.00 -> $41.00View Rating Details
8/5/2016Needham & Company LLCReiterated RatingBuy$49.00View Rating Details
6/22/2016Bank of America Corp.DowngradeBuy -> Neutral$40.00View Rating Details
5/22/2016Leerink SwannReiterated RatingHoldView Rating Details
3/28/2016JPMorgan Chase & Co.Reiterated RatingBuyView Rating Details
2/6/2015Roth CapitalReiterated RatingBuy$42.00View Rating Details
(Data available from 10/1/2014 forward)

Earnings

Earnings History for Acadia Pharmaceuticals (NASDAQ:ACAD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016        
8/4/2016Q216($0.49)($0.63)$0.71 million$0.97 millionViewListenView Earnings Details
5/5/2016Q116($0.42)($0.45)$0.22 millionViewListenView Earnings Details
2/29/2016Q415($0.38)($0.45)$0.02 millionViewListenView Earnings Details
11/5/2015Q315($0.40)($0.39)$0.05 million$0.04 millionViewListenView Earnings Details
8/6/2015Q215($0.33)($0.39)$0.06 millionViewListenView Earnings Details
5/7/2015Q115($0.27)($0.40)$0.09 millionViewListenView Earnings Details
2/26/2015Q414($0.26)($0.28)$0.08 million$0.05 millionViewListenView Earnings Details
11/10/2014Q3($0.12)($0.25)ViewListenView Earnings Details
8/5/2014Q2($0.17)($0.22)ViewListenView Earnings Details
5/6/2014Q1($0.13)($0.19)ViewListenView Earnings Details
2/27/2014Q4($0.14)($0.13)ViewListenView Earnings Details
8/6/2013Q2 2013($0.09)($0.11)$0.45 million$451.00 millionViewListenView Earnings Details
5/7/2013Q1 2013($0.08)($0.08)$0.45 million$0.42 millionViewListenView Earnings Details
11/5/2012Q312($0.09)($0.04)$1.90 million$3.50 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Acadia Pharmaceuticals (NASDAQ:ACAD)
Current Year EPS Consensus Estimate: $-2.05 EPS
Next Year EPS Consensus Estimate: $-1.46 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.44)($0.44)($0.44)
Q2 20161($0.46)($0.46)($0.46)
Q3 20161($0.48)($0.48)($0.48)
Q4 20161($0.43)($0.43)($0.43)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Acadia Pharmaceuticals (NASDAQ:ACAD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Acadia Pharmaceuticals (NASDAQ:ACAD)
Insider Ownership Percentage: 21.65%
Institutional Ownership Percentage: 92.10%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/16/2016Edmund HarriganDirectorBuy1,000$32.97$32,970.00View SEC Filing  
8/10/2016Bros. Advisors Lp BakerDirectorBuy1,303,030$33.00$42,999,990.00View SEC Filing  
7/12/2016Glenn BaityEVPSell16,000$35.00$560,000.00View SEC Filing  
7/11/2016Glenn BaityEVPSell4,057$35.00$141,995.00View SEC Filing  
4/18/2016Leslie L IversenDirectorSell33,697$33.53$1,129,860.41View SEC Filing  
4/1/2016Bros. Advisors Lp BakerDirectorBuy1,449,090$27.08$39,241,357.20View SEC Filing  
1/7/2016L.P. 14159DirectorBuy2,586,206$29.00$74,999,974.00View SEC Filing  
11/11/2015Leslie L. IversenDirectorSell30,000$36.01$1,080,300.00View SEC Filing  
1/15/2015Michael T BorerDirectorSell27,973$33.02$923,668.46View SEC Filing  
1/14/2015Uli HacksellCEOSell30,000$33.98$1,019,400.00View SEC Filing  
12/15/2014Mary Ann GrayDirectorSell12,250$31.74$388,815.00View SEC Filing  
12/15/2014Uli HacksellCEOSell30,000$31.00$930,000.00View SEC Filing  
11/26/2014Michael T BorerDirectorSell15,000$30.05$450,750.00View SEC Filing  
11/26/2014Roger MillsCMOSell25,000$30.09$752,250.00View SEC Filing  
11/24/2014Uli HacksellCEOSell30,000$29.28$878,400.00View SEC Filing  
11/21/2014William Mcdowall WellsDirectorSell5,810$29.00$168,490.00View SEC Filing  
10/8/2014Uli HacksellCEOSell30,000$24.15$724,500.00View SEC Filing  
9/15/2014Laura BregeDirectorSell10,000$28.07$280,700.00View SEC Filing  
9/12/2014William Mcdowall WellsDirectorSell9,190$29.15$267,888.50View SEC Filing  
9/10/2014Uli HacksellCEOSell30,000$27.36$820,800.00View SEC Filing  
8/15/2014Uli HacksellCEOSell15,000$22.89$343,350.00View SEC Filing  
7/14/2014Uli HacksellCEOSell20,000$22.22$444,400.00View SEC Filing  
6/16/2014Uli HacksellCEOSell20,000$23.10$462,000.00View SEC Filing  
6/9/2014William Mcdowall WellsDirectorSell15,000$23.03$345,450.00View SEC Filing  
5/1/2014Torsten RasmussenDirectorSell32,857$20.03$658,125.71View SEC Filing  
4/15/2014Uli HacksellCEOSell25,000$17.75$443,750.00View SEC Filing  
4/4/2014Thomas AasenCFOSell15,000$22.48$337,200.00View SEC Filing  
4/4/2014Torsten RasmussenDirectorSell30,000$21.98$659,400.00View SEC Filing  
3/5/2014Bros. Advisors Lp BakerDirectorBuy526,316$28.50$15,000,006.00View SEC Filing  
2/26/2014Glenn BaityVPSell42,000$30.28$1,271,760.00View SEC Filing  
11/1/2013Torsten RasmussenDirectorSell37,692$23.00$866,916.00View SEC Filing  
11/1/2013Uli HacksellCEOSell15,000$23.24$348,600.00View SEC Filing  
10/10/2013Laura BregeDirectorSell10,000$21.63$216,300.00View SEC Filing  
10/1/2013Thomas H AasenCFOSell30,000$27.87$836,100.00View SEC Filing  
9/20/2013Roger MillsCMOSell35,965$25.01$899,484.65View SEC Filing  
9/12/2013Lester Ph KaplanDirectorSell66,356$22.90$1,519,552.40View SEC Filing  
9/10/2013Laura BregeDirectorSell46,153$22.80$1,052,288.40View SEC Filing  
9/3/2013Torsten RasmussenDirectorSell40,000$20.28$811,200.00View SEC Filing  
8/26/2013Mary Ann GrayDirectorSell15,000$20.68$310,200.00View SEC Filing  
8/13/2013Thomas AasenCFOSell60,000$20.15$1,209,000.00View SEC Filing  
8/13/2013Uli HacksellCEOSell52,771$20.14$1,062,807.94View SEC Filing  
6/5/2013Felix BakerDirectorBuy2,340,314$14.34$33,560,102.76View SEC Filing  
5/15/2013Felix BakerDirectorBuy1,993,000$12.50$24,912,500.00View SEC Filing  
4/12/2013Glenn BaityVPSell60,000$12.42$745,200.00View SEC Filing  
4/11/2013Thomas H AasenCFOSell40,000$11.06$442,400.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Acadia Pharmaceuticals (NASDAQ:ACAD)
DateHeadline
News IconNews review of 2 biotech stocks: Celgene Corporation (NASDAQ:CELG), ACADIA Pharmaceuticals Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:ACAD)
voiceregistrar.com - October 1 at 8:10 AM
schaeffersresearch.com logoOptions Traders Bet On ACADIA Pharmaceuticals Inc. (ACAD) Breaking Lower - Schaeffers Research (blog) (NASDAQ:ACAD)
www.schaeffersresearch.com - October 1 at 8:10 AM
smarteranalyst.com logoCowen Chimes in on ACADIA Pharmaceuticals Inc. (ACAD) Amid Slow But Steady Nuplazid Launch (NASDAQ:ACAD)
www.smarteranalyst.com - September 30 at 3:19 PM
schaeffersresearch.com logoOptions Traders Bet On ACADIA Pharmaceuticals Inc. (ACAD) Breaking Lower (NASDAQ:ACAD)
www.schaeffersresearch.com - September 30 at 3:19 PM
News IconHot Biotech Stocks To Watch Right Now: ACADIA Pharmaceuticals Inc. (ACAD), Clovis Oncology, Inc. (CLVS) - The Independent Republic (NASDAQ:ACAD)
theindependentrepublic.com - September 29 at 3:13 PM
benzinga.com logoBenzinga's M&A Chatter for Wednesday September 28, 2016 - Benzinga (NASDAQ:ACAD)
www.benzinga.com - September 29 at 8:00 AM
smarteranalyst.com logoCowen Chimes in on ACADIA Pharmaceuticals Inc. (ACAD) Amid Slow But Steady Nuplazid Launch - Smarter Analyst (NASDAQ:ACAD)
www.smarteranalyst.com - September 29 at 8:00 AM
News IconBiotech news that matter for investors: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Acorda Therapeutics, Inc ... - The Voice Registrar (NASDAQ:ACAD)
voiceregistrar.com - September 28 at 3:13 PM
News IconNews review of 2 biotech stocks: XOMA Corporation (NASDAQ:XOMA), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) - The Voice Registrar (NASDAQ:ACAD)
voiceregistrar.com - September 27 at 3:15 PM
News IconHot Biotech Stocks Recap: Clovis Oncology, Inc. (NASDAQ:CLVS), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) - The Voice Registrar (NASDAQ:ACAD)
voiceregistrar.com - September 26 at 3:15 PM
smarteranalyst.com logoHC Wainwright Reiterates Upbeat View on ACADIA Pharmaceuticals Inc. (ACAD) Following Management Meeting - Smarter Analyst (NASDAQ:ACAD)
www.smarteranalyst.com - September 24 at 8:06 AM
investors.com logoAxovant Confidence 'Not Swayed' After Rival Alzheimer's Drug Fails (NASDAQ:ACAD)
www.investors.com - September 23 at 3:19 PM
fool.com logoA Critical Couple of Months for Acadia Pharmaceuticals (NASDAQ:ACAD)
www.fool.com - September 23 at 8:02 AM
News Icon2 Biotech Stocks News And Price Trends: Tesaro, Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:ACAD)
voiceregistrar.com - September 22 at 3:15 PM
News IconAcadia Pharmaceuticals Inc. (ACAD) Stock Price Down 2.6% - NewsDen (NASDAQ:ACAD)
newsden.net - September 22 at 8:10 AM
News IconACADIA Pharmaceuticals Inc.'s (ACAD): Seeing Active Stock of Yesterday - Hot Stocks Point (NASDAQ:ACAD)
www.hotstockspoint.com - September 22 at 8:10 AM
News IconHot Biotech Stocks Recap: ACADIA Pharmaceuticals (NASDAQ:ACAD), Puma Biotechnology (NYSE:PBYI) - The Voice Registrar (NASDAQ:ACAD)
voiceregistrar.com - September 22 at 8:10 AM
News IconSolarCity Corp (NASDAQ:SCTY) & ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Worth Watching Stocks - Money News (NASDAQ:ACAD)
www.newsismoney.com - September 21 at 3:21 PM
News IconAnalysts Valuations For Two Stocks: E*TRADE Financial Corp (NASDAQ:ETFC), ACADIA Pharmaceuticals Inc ... - The Voice Registrar (NASDAQ:ACAD)
voiceregistrar.com - September 21 at 3:21 PM
businesswire.com logoACADIA Pharmaceuticals to Present at the Ladenburg Thalmann 2016 Healthcare Conference on September 27, 2016 - Business Wire (press release) (NASDAQ:ACAD)
www.businesswire.com - September 20 at 3:15 PM
businesswire.com logoACADIA Pharmaceuticals Sponsors National Parkinson Foundation's Caregiver Summit - Business Wire (press release) (NASDAQ:ACAD)
www.businesswire.com - September 20 at 3:15 PM
finance.yahoo.com logoACADIA Pharmaceuticals to Present at the Ladenburg Thalmann 2016 Healthcare Conference on September 27, 2016 (NASDAQ:ACAD)
finance.yahoo.com - September 20 at 9:01 AM
publicnow.com logoACADIA Pharmaceuticals Sponsors National Parkinson Foundation’s Caregiver Summit (NASDAQ:ACAD)
www.publicnow.com - September 19 at 4:06 PM
capitalcube.com logoACADIA Pharmaceuticals, Inc. – Value Analysis (NASDAQ:ACAD) : September 19, 2016 (NASDAQ:ACAD)
www.capitalcube.com - September 19 at 4:06 PM
News IconIntraday Active Biotech Stocks News: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Keryx Biopharmaceuticals Inc ... - The Voice Registrar (NASDAQ:ACAD)
voiceregistrar.com - September 16 at 3:16 PM
capitalcube.com logoACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ACAD-US : September 16, 2016 (NASDAQ:ACAD)
www.capitalcube.com - September 16 at 11:57 AM
News IconAnalysts Valuations For Two Stocks: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), TransUnion (NYSE:TRU) - The Voice Registrar (NASDAQ:ACAD)
voiceregistrar.com - September 15 at 8:27 PM
News IconACADIA Pharmaceuticals Inc. Can't Be More Safe. Trades Significantly Higher - Chester News (NASDAQ:ACAD)
www.chesterindependent.com - September 15 at 3:16 PM
prnewswire.com logoBiotech Stocks on Investors' Radar -- Eleven Biotherapeutics, CytRx, Celldex Therapeutics, and ACADIA Pharma - PR Newswire (press release) (NASDAQ:ACAD)
www.prnewswire.com - September 14 at 3:14 PM
News IconHC Stocks Overview= ACADIA Pharmaceuticals Inc. (ACAD), Athersys, Inc. (NASDAQ:ATHX) - share market updates (press release) (NASDAQ:ACAD)
sharemarketupdates.com - September 14 at 10:00 AM
News IconAnalysts Buzz at Active Mover- Provectus Biopharmaceuticals, Inc. (NYSE:PVCT), ACADIA Pharmaceuticals Inc ... - Seneca Globe (NASDAQ:ACAD)
www.senecaglobe.com - September 12 at 3:15 PM
News IconStock on the Rise Over the Last Half Year: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) - Post News (NASDAQ:ACAD)
www.kentuckypostnews.com - September 12 at 8:01 AM
News IconWhy ACADIA Pharmaceuticals Tumbled 13.3% in August - Fox Business (NASDAQ:ACAD)
www.foxbusiness.com - September 12 at 8:01 AM
fool.com logo3 Stocks Begging for a Buyout (NASDAQ:ACAD)
www.fool.com - September 12 at 8:01 AM
fool.com logoWhy ACADIA Pharmaceuticals Tumbled 13.3% in August -- The ... - Motley Fool (NASDAQ:ACAD)
www.fool.com - September 11 at 3:13 PM
fool.com logoWhy ACADIA Pharmaceuticals Tumbled 13.3% in August (NASDAQ:ACAD)
www.fool.com - September 11 at 3:12 PM
News IconShares Lower Over the Past Quarter: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) - Post News (NASDAQ:ACAD)
www.kentuckypostnews.com - September 10 at 3:15 PM
News IconAnalysts Valuations For Two Stocks: Novavax, Inc. (NASDAQ:NVAX), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) - The Voice Registrar (NASDAQ:ACAD)
voiceregistrar.com - September 10 at 3:15 PM
stocksdaily.net logoWhat Is Mean Rating On ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)? - Stocks Daily (NASDAQ:ACAD)
www.stocksdaily.net - September 10 at 3:15 PM
fool.com logo3 Mid-Cap Healthcare Stocks You Can Buy Right Now (NASDAQ:ACAD)
www.fool.com - September 10 at 3:15 PM
News IconBiotech Stocks Worth a Closer Look: Novavax, Inc. (NASDAQ:NVAX ... - The Voice Registrar (NASDAQ:ACAD)
voiceregistrar.com - September 10 at 8:01 AM
News IconACADIA Pharmaceuticals Inc. (NASDAQ:ACAD): What is the Sell-side Making of this Stock? - Post News (NASDAQ:ACAD)
www.kentuckypostnews.com - September 9 at 8:02 AM
News IconBiotech news that matter for investors: Cerus Corporation (NASDAQ:CERS), ACADIA Pharmaceuticals Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:ACAD)
voiceregistrar.com - September 8 at 12:15 PM
News IconAnalysts Valuations For Two Stocks: ACADIA Pharmaceuticals Inc ... - The Voice Registrar (NASDAQ:ACAD)
voiceregistrar.com - September 7 at 8:24 PM
News IconACADIA Pharmaceuticals to Present at the Morgan Stanley Global Healthcare ... (NASDAQ:ACAD)
sports.yahoo.com - September 7 at 12:11 PM
businesswire.com logoACADIA Pharmaceuticals to Present at the Morgan Stanley Global ... - Business Wire (press release) (NASDAQ:ACAD)
www.businesswire.com - September 6 at 3:12 PM
News IconIntraday Active Biotech Stocks News: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), ACADIA Pharmaceuticals Inc ... - The Voice Registrar (NASDAQ:ACAD)
voiceregistrar.com - September 6 at 3:12 PM
finance.yahoo.com logoACADIA Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference on September 12, 2016 (NASDAQ:ACAD)
finance.yahoo.com - September 6 at 3:12 PM
News IconHC Stocks Summary- Immunomedics, Inc. (IMMU), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) - share market updates (press release) (NASDAQ:ACAD)
sharemarketupdates.com - September 6 at 8:01 AM
News IconAcadia Pharmaceuticals Inc Pipeline Review, Industry Analysis, Market Size and Forecast 2016 – 2020 (NASDAQ:ACAD)
www.medgadget.com - September 5 at 3:15 PM

Social

Acadia Pharmaceuticals (NASDAQ:ACAD) Chart for Saturday, October, 1, 2016


Last Updated on 10/1/2016 by MarketBeat.com Staff